Hepatitis C virus genotypes in injecting drug users from Romania

Central European Journal of Medicine

Volumn 6, Issue 5, 2011, Pages 672-678

  Sultana, Camelia ^a,b   Vagu, Codruta ^b   Temereanca, Aura ^a,b   Grancea, Camelia ^b   Slobozeanu, Josefina ^c   Ruta, Simona ^a,b  

^a CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^b STEFAN S NICOLAU INSTITUTE OF VIROLOGY   (Romania)

^c Center for Integrated Assistance for Addicts CAIA Pantelimon   (Romania)

Author keywords

HCV genotypes; HCV prevalence; Injecting drug users; Romania

Indexed keywords

HEPATITIS ANTIBODY; HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIGEN; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; HUMAN T CELL LEUKEMIA VIRUS ANTIBODY;

ADULT; AGE DISTRIBUTION; ANTIBODY DETECTION; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; FEMALE; GENE LOCATION; GENOTYPE; HEPATITIS B; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; INTRAVENOUS DRUG ABUSE; MALE; PRIORITY JOURNAL; ROMANIA; SEROPREVALENCE; VIRAL GENETICS; VIRUS LOAD; VIRUS STRAIN;

EID: 81355141969     PISSN: 18951058     EISSN: 16443640     Source Type: Journal    
DOI: 10.2478/s11536-011-0073-6     Document Type: Article

References (33)

1. European Centre for Disease Prevention and Control, Surveillance and Prevention of Hepatitis B and C in Europe, ECDC, Stockholm, 2010
2. European Centre for Disease Prevention and Control, Annual Epidemiological Report on Communicable Diseases in Europe 2010, ECDC, Stockholm, 2010
3. Esteban J.I., Sauleda S., Quer J., The changing epidemiology of hepatitis C virus infection in Europe, J. Hepatol., 2008, 48, 148-162 (Pubitemid 350191999)
4. European Monitoring Centre for Drugs and Drug Addiction, Annual report on the state of the drugs problem in Europe, EMCDDA, Lisbon, 2010
5. Gheorghe L., Csiki I.E., Iacob S., Gheorghe C., Smira R., Regep L., The prevalence and risk factors of hepatitis C virus infection in adult population in Romania: a nationwide survey 2006 - 2008, J. Gastrointestin. Liver Dis., 2010, 19(4), 373-379
6. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) and National Antidrug Agency from Romania (NAA), National report on drugs situation for Romania, New developments, trends and in-depth information on selected issues, REITOX, Bucharest, 2010
7. United Nation on Drugs and Crime, HIV, HBV and HCV behavioral surveillance survey among injecting drug users in Bucharest, Romania, Speed Promotion, Bucharest, 2010
8. Rantala M., Van de Laar M., Surveillance and epidemiology of hepatitis B and C in Europe - a review, Eurosurveillance, 2008, http://www. eurosurveillance.org/2008/13/21/reviews/18880
9. Grigorescu M., HCV genotype 1 is almost exclusively present in Romanian patients with chronic hepatitis C, J. Gastrointestin. Liver Dis., 2009, 18(1), 45-50
10. Sutton A.J., Hope V.D., Mathei C., Mravcik V., Sebakova H., Vallejo F., et al., A comparison between the force of infection estimates for bloodborne viruses in injecting drug user populations across the European Union: a modelling study, J. Viral Hepatitis, 2008,15(11), 809-816
11. UNGASS, Country Progress Report for Romania, Reporting period: January 2008-December 2009, UNGASS, Romania, 2010
12. Bourlière M., Barberin J.M., Rotily M., Guagliardo V., Portal I., Lecomte L., et al., Epidemiological changes in hepatitis C virus genotypes in France: evidence in intravenous drug users, J. Viral Hepatitis, 2002, 9(1), 62-70 (Pubitemid 36002488)
13. Huppe D., Zehnter E., Mauss S., Boker K., Lutz T., Racky S., et al., Epidemiology of chronic hepatitis C in Germany-an analysis of 10,326 patients in hepatitis centres and outpatient units, Z. Gastroenterol., 2008, 46(1), 34-44 (Pubitemid 351261948)
14. Cenci M., De Soccio G., Recchia O., Prevalence of hepatitis C virus (HCV) genotypes in central Italy, Anticancer Res., 2003, 23(6D), 5129-5132 (Pubitemid 38182135)
15. Nemecek V., Strunecký O., Genotypic heterogeneity of hepatitis C virus (HCV) from blood donors in the Czech Republic, Epidemiol. Mikrobiol. Imunol., 2009, 58(2), 63-72
16. Chlabicz S., Flisiak R., Kowalczuk O., Grzeszczuk A., Pytel-Krolczuk B., Prokopowicz D, et al., Changing HCV genotypes distribution in Poland - Relation to source and time of infection, J.Clin. Virol., 2008, 42(2), 156-159
17. Svirtlih N., Delic D., Simonovic J., Jevtovic D., Dokic L., Gvozdenovic E., et al., Hepatitis C virus genotypes in Serbia and Montenegro: The prevalence and clinical significance, World J. Gastroenterol., 2007, 13(3), 355-360 (Pubitemid 46178968)
18. Ahmetagić S., Salkić N., Čičkuš ić E., Zerem E., Mott- Divković S., Tihić N., Hepatitis C virus genotypes in chronic hepatitis C patients and in first time blood donors in Northeastern Bosnia and Herzegovina, Bosnian Journal of Basic Medical Sciences, 2009, 9 (4), 278-282
19. Paintsil E., Verevochkin S.V., Dukhovlinova E., Niccolai L., Barbour R., White E., et al., Hepatitis C virus infection among drug injectors in St Petersburg, Russia: social and molecular epidemiology of an endemic infection, Addiction., 2009, 104(11), 1881-1890
20. Tallo T., Norder H., Tefanova V., Krispin T., Schmidt J., Ilmoja M., et al. Genetic characterization of hepatitis C virus strains in Estonia: fluctuations in the predominating subtype with time, J. Med. Virol., 2007, 79, 374-382 (Pubitemid 46355436)
21. Colina R., Casane D., Vasquez S., García-Aguirr L., Chunga A., Romero H., et al., Evidence of intratypic recombination in natural populations of hepatitis C virus, J. Gen. Virol., 2004, 85, 31-37 (Pubitemid 38128867)
22. Kalinina O., Norder H., Magnius L.O., Full-length open reading frame of a recombinant hepatitis C virus strain from St Petersburg: proposed mechanism for its formation, J. Gen. Virol., 2004, 85, 1853-1857 (Pubitemid 39023263)
23. Van de Laar T.J., Van der Bij A.K., Prins M., Increase in HCV incidence among men who have sex with men in Amsterdam most likely caused by sexual transmission. J. Infect. Dis., 2007, 196, 230-238 (Pubitemid 47047462)
24. Danta M., Brown D., Bhagani S., Recent epidemic of acute hepatitis C virus in HIV-positive men who have sex with men linked to high-risk sexual behaviours, AIDS, 2007, 21, 983-991 (Pubitemid 46684329)
25. Pitigoi D., Rafila A., Pistol A., Arama V., Molagic V., Streinu-Cercel A., Trends in hepatitis B incidence in Romania, 1989-2005, Eurosurveillance, 2008, 13(1-3), 70-74
26. Paintsil E., He H., Peters C., Lindenbach B.D., Heimer R., Survival of Hepatitis C Virus in Syringes: Implication for Transmission among Injection Drug Users, J. Infect. Dis., 2010, 202(7), 984-990
27. Huik K., Sadam M., Karki T., Avi R., Krispin T., Paap P., et al., CCL3L1 Copy Number is a strong genetic determinant of HIV seropositivity in caucasian intravenous drug users, J. Infect. Dis., 2010, 201(5), 730-739
28. Ruta S.M., Matusa R.F., Sultana C., Manolescu L., Kozinetz C.A., Kline M., et al., High prevalence of hepatitis B virus markers in Romanian adolescents with HIV, Med. Gen. Med., 2005, 7, 68-72
29. National AIDS Committee, Department for AIDS monitoring from Romania, Statistic data on HIV/ AIDS infection in Romania, CNLAS, Bucharest, 2010 (in Romanian)
30. EuroHIV, HIV/AIDS Surveillance in Europe. Midyear report 2007 No.76, French Institute for Public Health Surveillance, Saint-Maurice, 2007
31. Shakarishvili A., Dubovskaya L.K., Zohrabyan L.S., St Lawrence J.S., Aral S.O., Dugasheva L.G., et al., Sex work, drug use, HIV infection, and spread of sexually transmitted infections in Moscow, Russian Federation, Lancet, 2005, 366, 57-60 (Pubitemid 40956531)
32. Jabłonowska E., Małolepsza E., Causes of death in HIV-infected patients in the region of Lodz, Poland from 1995 through 2005, Cent. Eur. J. Med., 2009, 4(2), 179-183
33. Joint United Nations Programme on HIV/AIDS, The Changing HIV/AIDS Epidemic in Europe and Central Asia, UNAIDS, WHO Library, Geneva, 2004